Skip to Main Content

Paper Details

Expanded Multivariable Models to Assist Patient Selection for Long-Acting Cabotegravir + Rilpivirine Treatment: Clinical Utility of a Combination of Patient, Drug Concentration, and Viral Factors Associated With Virologic Failure.
Clin Infect Dis
18
2023
A1, A6, CAB, CVF, Cabotegravir, Patient, RPV, Rilpivirine, cabotegravir, human immunodeficiency virus-1, participants, rilpivirine
Author NameAffiliation
Daniel R KuritzkesBrigham and Women's Hospital, Harvard Medical School
Daniel R KuritzkesBrigham and Women's Hospital, Harvard Medical School
  • 1 - 2

Datasets

Release 1.2